Inventiva (IVA) Cash & Equivalents (2018 - 2025)

Inventiva (IVA) recorded quarterly Cash & Equivalents of $115.6 million in Q4 2025, up 5.75% quarter-over-quarter from $109.3 million in Q2 2025, and up 11.98% on a YoY basis from $103.2 million in Q4 2024.

Inventiva (IVA) Cash & Equivalents (2018 - 2025) Analysis & Trends

Inventiva's Cash & Equivalents history runs 8 years deep, the most recent figure standing at $115.6 million for Q4 2025.

  • In Q4 2025, Cash & Equivalents rose 11.98% year-over-year to $115.6 million; the TTM figure through Dec 2025 stood at $115.6 million (up 11.98% YoY), while the FY2025 annual figure was $115.6 million, up 11.98% from the prior year.
  • Cash & Equivalents was $115.6 million for Q4 2025 at Inventiva, up from $109.3 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $130.0 million in Q1 2021 to a low of $9.7 million in Q4 2023.
  • Historically, Cash & Equivalents has averaged $84.7 million across 5 years, with a median of $94.4 million in 2023.
  • The sharpest annual moves came in 2023 and 2024: Cash & Equivalents sank 89.08% in 2023, then soared 967.79% in 2024.
  • A 5-year view of Cash & Equivalents shows it stood at $99.0 million in 2021, then fell by 10.63% to $88.5 million in 2022, then tumbled by 89.08% to $9.7 million in 2023, then surged by 967.79% to $103.2 million in 2024, then gained by 11.98% to $115.6 million in 2025.
  • The last three Cash & Equivalents figures came in at $115.6 million (Q4 2025), $109.3 million (Q2 2025), and $103.2 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Alterity Therapeutics 788,338.31 Bn 788,338.28 Bn - 32.30 Mn
2 Belite Bio 56,560.00 Bn 56,560.00 Bn - -
3 Quantum Biopharma 17,329.30 Bn 17,329.30 Bn - 1.91 Mn
4 Legend Biotech 3,341.00 Bn 3,340.71 Bn 242.10 Mn 286.70 Mn
5 Akari Therapeutics 1,727.91 Bn 1,727.91 Bn - 2.77 Mn
6 Evaxion A 1,536.68 Bn 1,536.67 Bn - 18.44 Mn
7 Psyence Biomedical 238.34 Bn 238.33 Bn - 7.15 Mn
8 Vertex Pharmaceuticals 113.42 Bn 106.17 Bn 2.59 Bn 5.49 Bn
9 Abivax 95.45 Bn 95.45 Bn - 558.94 Mn
10 Inventiva 8.93 Mn -259.80 Mn - 115.59 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 115.59 Mn
Jun 30, 2025 109.31 Mn
Dec 31, 2024 103.23 Mn
Jun 30, 2024 28.99 Mn
Dec 31, 2023 9.67 Mn
Oct 11, 2023 12.54 Mn
Jun 30, 2023 94.45 Mn
Dec 31, 2022 88.49 Mn
Sep 22, 2022 90.31 Mn
Jun 30, 2022 92.36 Mn
Dec 31, 2021 99.01 Mn
Jun 30, 2021 127.28 Mn
Mar 31, 2021 130.04 Mn
Dec 31, 2020 126.01 Mn
Jun 30, 2020 57.58 Mn
Mar 31, 2020 51.77 Mn
Dec 31, 2019 39.67 Mn
Dec 31, 2018 64.71 Mn